Abstract

BackgroundThe purpose of this study was to evaluate safety, technical success, and clinical outcomes of treatment for venous malformations using n-BCA glue embolization immediately prior to excision. Sixty three patients (22 male, 41 female; mean age 12 years (range 1–25)) who underwent 70 procedures for extremity and trunk venous malformations were reviewed. Indications for treatment included pain (100%), swelling (22%), and diminished range of motion (16%). Thirty seven patients (59%) had undergone prior stand-alone interventional or surgical treatment but were persistently symptomatic. Safety, technical and clinical success were retrospectively assessed.ResultsEmbolization was technically successful in 100% of patients. Mean lesion size was 3.0 × 2.9 × 5.7 cm. Three patients (5%) underwent planned, second stage procedures for lesions intentionally not treated at the first procedure. Four patients (6%) underwent an unplanned, second stage procedure for residual disease after the primary operation. Mean and median follow-up duration were 18 and 17 months, respectively (range 3 to 35 months). Symptomatic improvement was achieved in 58 patients (92%), of whom 41 (65%) reported complete elimination of pain. There were no recognized instances of nontarget embolization or other complications of the interventional procedure. One patient required additional surgery for wound dehiscence and one patient developed an abscess requiring incision and drainage. Minor surgical complications included surgical site skin infections (n = 5) and numbness (n = 1). Mean and median surgical blood loss volumes were 131 mL and 10 mL, respectively. One patient required perioperative blood transfusion.ConclusionsExtremity and truncal venous malformations can be safely and effectively treated in a single-stage fashion using glue embolization immediately preceding excision.

Highlights

  • The purpose of this study was to evaluate safety, technical success, and clinical outcomes of treatment for venous malformations using n-butyl cyanoacrylate (n-BCA) glue embolization immediately prior to excision

  • Venous malformation (VM) are typically soft and compressible but can become firm if intralesional thrombus develops; they commonly enlarge with Valsalva maneuver (Burrows & Mason, 2004)

  • VMs are present at birth but enlarge as the child grows, usually in proportion to the child’s growth with more accelerated growth seen during puberty

Read more

Summary

Introduction

The purpose of this study was to evaluate safety, technical success, and clinical outcomes of treatment for venous malformations using n-BCA glue embolization immediately prior to excision. Indications for treatment included pain (100%), swelling (22%), and diminished range of motion (16%). Venous malformations (VMs) represent the most common type of congenital vascular anomaly, with a prevalence of around 1% (Cahill & Nijs, 2011; Puig et al, 2005). These are structural, non-neoplastic malformations of veins characterized by dilated channels with a single layer of endothelium and a discontinuous smooth muscle covering (Boon et al, 2004) without normal. When the VM involves a joint or limb, limited range of motion (ROM) and gait disturbance may occur

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.